Roy F. Waldron

Roy F. Waldron serves on various advisory and board positions, including the Advisory Board for InsuLife and Pike Therapeutics, and the Board of Directors for Starton Therapeutics and the Renand Foundation, where Roy F. acts as Secretary. Previously, Waldron held significant roles at Pfizer as Senior Vice-President, Associate General Counsel, and Chief Intellectual Property Counsel from 1999 to 2018, and worked as an Associate at White & Case and Fish & Neave. Waldron's academic credentials include a JD from New York University School of Law, a PhD in Chemistry from Yale University, and post-doctoral studies in Computational Chemistry at Kyoto University, complemented by a BA in Chemistry from Dartmouth College.